Fe3O4/Au/porous Au nanohybrid for efficient delivery of doxorubicin as a model drug
Creators
- 1. Laboratory of Bioanalysis, Institute of Biochemistry and Biophysics, University of Tehran, Tehran (Iran, Islamic Republic of)
- 2. Medical Nanotechnology and Tissue Engineering Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd (Iran, Islamic Republic of)
Description
Fe3O4/Au/porous Au nanohybrids being bi-functional nanoparticles with magnetic properties and high porosity, were synthesized and used for drug delivery. To achieve this purpose, after Fe3O4 nanoparticles synthesis, a gold layer coats them to increase their stability. Then, to improve the loading capacity of Fe3O4/Au nanoparticles, a shell of porous gold was synthesized on the Fe3O4/Au surface by creating an Ag-Au nanohybrid layer on Fe3O4/Au and dissolving the metallic silver atoms in HNO3 (0.01 M). The DLS results show that the synthesized nanohybrid has an average size of 68.0 ± 7.7 nm and a zeta potential of − 28.1 ± 0.2 mV. Finally, doxorubicin (DOX), as a pharmaceutical agent, was loaded onto the Fe3O4/Au/porous Au nanohybrids. The prepared nano-drug enhanced the therapeutic efficacy of DOX on MCF-7 cancer cells compared to the free DOX. These results confirmed a 1.5 times improvement in the antitumor activity of DOX-loaded Fe3O4/Au/porous Au nanohybrids. Graphical
Additional details
Identifiers
Publishing Information
- Journal Title
- Microchimica Acta (Online)
- Journal Volume
- 190
- Journal Issue
- 3
- Journal Page Range
- p. 1-9
- ISSN
- 1436-5073
INIS
- Country of Publication
- Austria
- Country of Input or Organization
- Austria
- INIS RN
- 55057746
- Subject category
- S77: NANOSCIENCE AND NANOTECHNOLOGY; S37: INORGANIC, ORGANIC, PHYSICAL AND ANALYTICAL CHEMISTRY;
- Descriptors DEI
- DOXORUBICIN; DRUG DELIVERY; GOLD; IRON OXIDES; NANOCHEMISTRY; NANOMATERIALS; NANOPARTICLES; NEOPLASMS; SILVER; TUMOR CELLS
- Descriptors DEC
- ANIMAL CELLS; ANTIBIOTICS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC DRUGS; CHALCOGENIDES; CHEMISTRY; DISEASES; DRUGS; ELEMENTS; IRON COMPOUNDS; MATERIALS; METALS; ORGANIC COMPOUNDS; OXIDES; OXYGEN COMPOUNDS; PARTICLES; TRANSITION ELEMENT COMPOUNDS; TRANSITION ELEMENTS
Optional Information
- Copyright
- Copyright (c) 2023 The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature